Miami-Dade's Quest to Make Everyone Knowledgeable About PrEP
Kira Villamizar, Manager, Public Health Services, Florida Department of Health, Miami-Dade County
Imagine discovering the promise of pre-exposure prophylaxis (PrEP) for the first time and determining that it can lower your risk of becoming HIV positive. You get up the nerve to go to your primary care physician and ask him or her if you are a candidate for the treatment, and your doctor either dismisses your question or, even worse, has no idea what PrEP is.
Read more: Miami-Dade's Quest to Make Everyone Knowledgeable About PrEP
More HIV Research Highlights from CROI 2017
Carl W. Dieffenbach, Ph.D., the Director of the Division of AIDS at NIH's National Institute of Allergy and Infectious Diseases, sums up information provided on the second day of the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle
New scientific findings from two separate domains were among the key highlights shared during the second day of the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, according to Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH's National Institute of Allergy and Infectious Diseases (NIAID). Dr. Dieffenbach and his colleague Anne Rancourt joined us for a Facebook Live session to re-cap some of those findings.
More than a Name Change: AIDS.gov Becomes HIV.gov
The newly rebranded HIV.gov
We've changed our name from AIDS.gov to HIV.gov!
To learn more about our name change and the reasons behind it, view the Facebook Live discussion we held on Wednesday, June 7, with Dr. Richard Wolitski, Director of the HHS Office of HIV/AIDS and Infectious Disease Policy, Jesse Milan, Jr., President & CEO of AIDS United, and Kaye Hayes, Executive Director of the Presidential Advisory Council on HIV/AIDS.
Read more: More than a Name Change: AIDS.gov Becomes HIV.gov
National Academies Report Charts Course to Elimination of Hepatitis B and C in U.S.
Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Editor's Note: A newly released report outlining a national strategy for elimination of hepatitis B and C by 2030 has important implications for people living with HIV. An estimated 10% of people living with HIV are coinfected with hepatitis B and 25% are coinfected with hepatitis C. Given these intersections, hastening the end of hepatitis B and C will strengthen our national response to HIV reducing illness and death among PLWH.
Read more: National Academies Report Charts Course to Elimination of Hepatitis B and C in U.S.
National Healthcare Access Coalition Launches 17 City National Black Healthcare Access Tour
Demand Access: Coming to a City Near You.
A national healthcare coalition comprised of 15 national organizations and networks launches a 17 city Demand Access: Black Healthcare Access Tour to raise awareness about the importance of healthcare access in Black communities, mobilize communities to respond to recent threats to the Affordable Care Act (ACA/Obamacare), and help individuals sign up for insurance during the 2017 ACA open-enrollment period: November 1, 2017 thru December 15, 2017.